Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Huh

Showing results (331-340 of 365) with videos related to

Pageof 37
Sort By:
Gynecologic Oncology|March 19, 2018
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group studyRamez N Eskander, James Kauderer, Krishnansu S Tewari, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
ASCCP Colposcopy Standards: Risk-Based Colposcopy PracticeNicolas Wentzensen, Mark Schiffman, Michelle I Silver, et al.
Obstetrics and Gynecology|January 9, 2015
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceWarner K Huh, Kevin A Ault, David Chelmow, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic PracticeMichelle J Khan, Claudia L Werner, Teresa M Darragh, et al.
Gynecologic Oncology|August 29, 2009
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)Amanda Nickles Fader, David Starks, Paola A Gehrig, et al.
International Journal of Cancer|February 13, 2026
Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): A randomized, double-blind, placebo-controlled trialHelen C Stankiewicz Karita, Amalia S Magaret, David R Doody, et al.
Gynecologic Oncology|April 16, 2019
Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo populationAnna R Giuliano, Elmar A Joura, Suzanne M Garland, et al.
The New England Journal of Medicine|March 3, 2016
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian CancerJohn K Chan, Mark F Brady, Richard T Penson, et al.
Gynecologic Oncology|September 26, 2022
Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry studyGretchen E Glaser, Olivia D Lara, Bhavana Pothuri, et al.
Infectious Agents and Cancer|May 20, 2020
Cervical and oral human papillomavirus infection in women living with human immunodeficiency virus (HIV) and matched HIV-negative controls in BrazilTamy Taianne Suehiro, Gabrielle Marconi Zago Ferreira Damke, Edilson Damke, et al.
Pageof 37

Showing results (331-340 of 365) with videos related to

Sort By:
Pageof 37
Gynecologic Oncology|March 19, 2018
Correlation between Surgeon's assessment and radiographic evaluation of residual disease in women with advanced stage ovarian cancer reported to have undergone optimal surgical cytoreduction: An NRG Oncology/Gynecologic Oncology Group studyRamez N Eskander, James Kauderer, Krishnansu S Tewari, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
ASCCP Colposcopy Standards: Risk-Based Colposcopy PracticeNicolas Wentzensen, Mark Schiffman, Michelle I Silver, et al.
Obstetrics and Gynecology|January 9, 2015
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidanceWarner K Huh, Kevin A Ault, David Chelmow, et al.
Journal of Lower Genital Tract Disease|September 28, 2017
ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic PracticeMichelle J Khan, Claudia L Werner, Teresa M Darragh, et al.
Gynecologic Oncology|August 29, 2009
An updated clinicopathologic study of early-stage uterine papillary serous carcinoma (UPSC)Amanda Nickles Fader, David Starks, Paola A Gehrig, et al.
International Journal of Cancer|February 13, 2026
Nonavalent HPV vaccine to prevent recurrent anal or vulvar high-grade squamous intraepithelial lesions (VIVA trial): A randomized, double-blind, placebo-controlled trialHelen C Stankiewicz Karita, Amalia S Magaret, David R Doody, et al.
Gynecologic Oncology|April 16, 2019
Nine-valent HPV vaccine efficacy against related diseases and definitive therapy: comparison with historic placebo populationAnna R Giuliano, Elmar A Joura, Suzanne M Garland, et al.
The New England Journal of Medicine|March 3, 2016
Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian CancerJohn K Chan, Mark F Brady, Richard T Penson, et al.
Gynecologic Oncology|September 26, 2022
Clinical outcomes in patients with COVID-19 and gynecologic cancer: A society of gynecologic oncology COVID-19 and gynecologic cancer registry studyGretchen E Glaser, Olivia D Lara, Bhavana Pothuri, et al.
Infectious Agents and Cancer|May 20, 2020
Cervical and oral human papillomavirus infection in women living with human immunodeficiency virus (HIV) and matched HIV-negative controls in BrazilTamy Taianne Suehiro, Gabrielle Marconi Zago Ferreira Damke, Edilson Damke, et al.
Pageof 37